This HTML5 document contains 109 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dbpedia-shhttp://sh.dbpedia.org/resource/
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n19https://global.dbpedia.org/id/
umbel-rchttp://umbel.org/umbel/rc/
yagohttp://dbpedia.org/class/yago/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n22http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
freebasehttp://rdf.freebase.com/ns/
dbpedia-srhttp://sr.dbpedia.org/resource/
n16http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
dbpedia-vihttp://vi.dbpedia.org/resource/
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
goldhttp://purl.org/linguistics/gold/
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/
dbpedia-jahttp://ja.dbpedia.org/resource/

Statements

Subject Item
dbr:C31H39ClN2O8
dbo:wikiPageWikiLink
dbr:Lapaquistat
dbo:wikiPageRedirects
dbr:Lapaquistat
Subject Item
dbr:Farnesyl-diphosphate_farnesyltransferase
dbo:wikiPageWikiLink
dbr:Lapaquistat
Subject Item
dbr:Lapaquistat
rdf:type
yago:Part113809207 yago:WikicatAmides yago:Amide114724264 yago:Quintessence114847103 yago:Formula106816935 yago:Relation100031921 yago:Material114580897 yago:Statement106722453 dbo:Drug dbo:ChemicalSubstance yago:MolecularFormula106817173 wikidata:Q8386 n22:ChemicalObject yago:Chemical114806838 yago:Communication100033020 yago:Element114840755 yago:Message106598915 yago:OrganicCompound114727670 yago:Matter100020827 yago:WikicatPhenolEthers yago:Substance100019613 yago:PhysicalEntity100001930 yago:Compound114818238 yago:WikicatMolecularFormulas owl:Thing umbel-rc:DrugProduct yago:Abstraction100002137
rdfs:label
ラパキスタット Lapaquistat
rdfs:comment
ラパキスタット（Lapaquistat）はコレステロール低下作用を期待してかつて開発されていた化合物である。HMG-CoAレダクターゼを阻害するスタチンと異なり、ラパキスタットは下流のを阻害するのでメバロン酸経路を乱さないことから、副作用が低減することを見込まれていた。しかし、スタチン（メバロン酸経路を阻害する）が他の関連分子にも影響（蛋白質のプレニル化過程を含む）を与える事が臨床的に有用であることが明らかとなって来た。 2008年3月、安全性・有効性の両面から既存の医薬品に勝る点がないとしてラパキスタットの開発は中止された。開発コードTAK-475。 Lapaquistat (TAK-475) is a cholesterol-lowering drug candidate that was abandoned before being marketed. Unlike statins, which inhibit HMG-CoA reductase, lapaquistat metabolites inhibit squalene synthase, which is further downstream in the synthesis of cholesterol. It is hoped that side effects can be reduced by not disturbing the mevalonate pathway, which is important for other biochemical molecules besides cholesterol.However, there is increasing evidence that statins (which inhibit the mevalonate pathway) may be clinically useful because they affect these other molecules (including protein prenylation).
foaf:depiction
n16:Lapaquistat.svg
dcterms:subject
dbc:Chloroarenes dbc:Piperidines dbc:Hypolipidemic_agents dbc:Benzoxazepines dbc:Abandoned_drugs dbc:Carboxamides dbc:Phenol_ethers
dbo:wikiPageID
14387852
dbo:wikiPageRevisionID
992913550
dbo:wikiPageWikiLink
dbr:HMG-CoA_reductase dbr:Mevalonate_pathway dbc:Chloroarenes dbr:Knockout_mouse dbr:Cholesterol dbr:Squalene_synthase dbc:Piperidines dbc:Hypolipidemic_agents dbc:Benzoxazepines dbr:Prenylation dbc:Abandoned_drugs dbr:Statin dbr:Liver_damage dbc:Phenol_ethers dbc:Carboxamides
owl:sameAs
dbpedia-sr:Lapakvistat dbpedia-ja:ラパキスタット freebase:m.03d2785 dbpedia-vi:Lapaquistat n19:4piko wikidata:Q6488102 dbpedia-sh:Lapakvistat yago-res:Lapaquistat
dbp:wikiPageUsesTemplate
dbt:Fdacite dbt:Drugbox dbt:Reflist dbt:Cite_journal dbt:Chemspidercite dbt:Lipid_modifying_agents dbt:Cascite dbt:Drugbankcite dbt:Stdinchicite dbt:Cardiovascular-drug-stub dbt:Ebicite
dbo:thumbnail
n16:Lapaquistat.svg?width=300
dbp:atcPrefix
none
dbp:c
31
dbp:casNumber
189059
dbp:chembl
341976
dbp:chemspiderid
8135996
dbp:cl
1
dbp:h
39
dbp:iupacName
acetic acid
dbp:n
2
dbp:o
8
dbp:pubchem
9960389
dbp:smiles
O=CCC4CCNCC4
dbp:stdinchi
1
dbp:stdinchikey
HDGUKVZPMPJBFK-LEAFIULHSA-N
dbp:unii
PEZ79BV72X
dbp:verifiedfields
changed
dbp:verifiedrevid
462088993
dbo:abstract
ラパキスタット（Lapaquistat）はコレステロール低下作用を期待してかつて開発されていた化合物である。HMG-CoAレダクターゼを阻害するスタチンと異なり、ラパキスタットは下流のを阻害するのでメバロン酸経路を乱さないことから、副作用が低減することを見込まれていた。しかし、スタチン（メバロン酸経路を阻害する）が他の関連分子にも影響（蛋白質のプレニル化過程を含む）を与える事が臨床的に有用であることが明らかとなって来た。 2008年3月、安全性・有効性の両面から既存の医薬品に勝る点がないとしてラパキスタットの開発は中止された。開発コードTAK-475。 Lapaquistat (TAK-475) is a cholesterol-lowering drug candidate that was abandoned before being marketed. Unlike statins, which inhibit HMG-CoA reductase, lapaquistat metabolites inhibit squalene synthase, which is further downstream in the synthesis of cholesterol. It is hoped that side effects can be reduced by not disturbing the mevalonate pathway, which is important for other biochemical molecules besides cholesterol.However, there is increasing evidence that statins (which inhibit the mevalonate pathway) may be clinically useful because they affect these other molecules (including protein prenylation). On March 28, 2008, Takeda halted further development of lapaquistat. While effective at lowering low-density lipoprotein cholesterol in a dose-dependent manner, development of the drug was ceased due to observations in clinical trials that it might cause liver damage in the high dose trial groups. Data from knockout mouse studies suggests that accumulation of high levels of the metabolic substrate of squalene synthase and derivatives thereof account for the liver toxicity of squalene synthase inhibitors, and efforts to mitigate this substrate accumulation would likely be necessary for clinical success of a squalene synthase inhibitor
gold:hypernym
dbr:Drug
prov:wasDerivedFrom
wikipedia-en:Lapaquistat?oldid=992913550&ns=0
dbo:wikiPageLength
4806
dbo:casNumber
189059-71-0
dbo:chEMBL
341976
dbo:fdaUniiCode
PEZ79BV72X
dbo:pubchem
9960389
foaf:isPrimaryTopicOf
wikipedia-en:Lapaquistat
Subject Item
dbr:Lapaquistat_acetate
dbo:wikiPageWikiLink
dbr:Lapaquistat
dbo:wikiPageRedirects
dbr:Lapaquistat
Subject Item
wikipedia-en:Lapaquistat
foaf:primaryTopic
dbr:Lapaquistat